2,2'-Dimethoxy-4,4'-bipyridine

Catalog No.: 
ACVOBL845
CAS No.: 
142929-11-1
Molecular Formula: 
C12H12N2O2
Molecular Weight: 
216.24
2,2'-Dimethoxy-4,4'-bipyridine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$77.00In stockInquiry
1g95%$204.00In stockInquiry
5g95%$709.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2,2'-Dimethoxy-4,4'-bipyridine
IUPAC Name2,2'-dimethoxy-4,4'-bipyridine
Molecular FormulaC12H12N2O2
Molecular Weight216.24
SMILESCOC1=NC=CC(C2=CC(OC)=NC=C2)=C1
InChI KeyZVEFTYPMUQYVTH-UHFFFAOYSA-N
Synonym2,2'-dimethoxy-4,4'-bipyridine;4,4'-Bipyridine, 2,2'-diMethoxy-
CAS No.142929-11-1
PubChem CID15019796

Safety Data

Pictogram
Toxic
Signal Word
Danger
Precautionary Statement(s)
P264-P270-P301+P310+P330-P405-P501

Synthetic Route by SureRoute

1. ACVOBL845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACYKOM382 route compound structure diagram
    ACYKOM382408502-23-8In Stock
  2. Plus
  3. ACXWMJ145 route compound structure diagram
    ACXWMJ145100367-39-3In Stock
  4. Then
  5. ACVOBL845 route product structure diagram
    ACVOBL845142929-11-1In Stock
Inquiry

2. ACVOBL845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACADOQ803 route compound structure diagram
    ACADOQ803762262-09-9In Stock
  2. Plus
  3. ACXWMJ145 route compound structure diagram
    ACXWMJ145100367-39-3In Stock
  4. Then
  5. ACVOBL845 route product structure diagram
    ACVOBL845142929-11-1In Stock
Inquiry

3. ACVOBL845 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACADOQ803 route compound structure diagram
    ACADOQ803762262-09-9In Stock
  2. Plus
  3. ACADOQ803 route compound structure diagram
    ACADOQ803762262-09-9In Stock
  4. Then
  5. ACVOBL845 route product structure diagram
    ACVOBL845142929-11-1In Stock
Inquiry

Comments (0)